Copy
View this email in your browser
         Vol. 3, No. 17                                                                                                           August 26, 2020

Cancer Institute Member Spotlight

Alan Diekman, Ph.D.

Professor
Department of Biochemistry and Molecular Biology
Department of Urology
UAMS College of Medicine

Research in the Diekman laboratory focuses on galectin-3, a carbohydrate-binding protein, in cancer and normal male reproductive function. Galectin-3 is implicated in the progression of multiple cancers, including prostate and breast cancer.  Read more>
$10.6 Million Federal Grant to Expand
National Proteomics Resource at UAMS
A $10.6 million grant from the National Institutes of Health (NIH) will allow UAMS to greatly expand its proteomics resource. This grant will establish the IDeA National Resource for Quantitative Proteomics as the first NIH National Resource in Arkansas, which will serve biomedical researchers across the entire nation. 

The five-year grant was awarded to Alan Tackett, Ph.D., associate director for basic science at the UAMS Winthrop P. Rockefeller Cancer Institute. Tackett serves as an administrative director of this new national resource. 
Read more>
Register now for Arkansas Cancer Coalition
Quarterly Meeting 
Registration is open for the virtual Arkansas Cancer Coalition (ACC) Quarterly Meeting scheduled for 10-11a.m. Sept. 8.

This meeting will feature a panel from the UAMS Cancer Institute to discuss lung cancer in the COVID-19 era. Trena Mitchell, ACC executive director, will also announce the ACC FY21 grantees.

Meeting ID information will be emailed to you when you register. If you have not used WebEx in the past, you may be prompted to download the CISCO WebEx app.
Cancer-related Research Funding Opportunities
 Extramural Opportunities

Notice of Special Interest (NOSI): Advancing Cancer Data Repositories and Knowledgebases

Integrating Biospecimen Science Approaches into Clinical Assay Development

Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional)

Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)

Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)

Advancing Research to Develop Improved Measures and Methods for Understanding Multimorbidity (R01 Clinical Trial Optional)

Identifying Innovative Mechanisms or Interventions that Target Multimorbidity and Its Consequences (R01 Clinical Trial Optional)

DoD Kidney Cancer, Clinical Consortium – Clinical Trial Site Award

DoD Kidney Cancer, Postdoctoral and Clinical Fellowship Award

DoD Kidney Cancer, Idea Development Award

DoD Prostate Cancer, Idea Development Award

DoD Prostate Cancer, Prostate Cancer Pathology Resource Network Award

Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R01 Clinical Trial Optional)

Strengthening Institutional Capacity to Conduct Global Cancer Research in Low- and Middle-Income Countries (D43 Clinical Trial Not Allowed)

DoD, Breast Cancer, Breakthrough Award Levels 1 and 2

DoD, Breast Cancer, Breakthrough Award Level 3

DoD, Breast Cancer, Breakthrough Award Level 4

DoD, Breast Cancer, Innovator Award

DoD Breast Cancer, Era of Hope Scholar Award

DoD Kidney Cancer Research Program Translational Research Partnership Award

DOD Kidney Cancer, Postdoctoral and Clinical Fellowship Award

Multilevel Interventions in Cancer Care Delivery: Follow-up to Abnormal Screening Tests

Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R01)

Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R21)

Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01 Clinical Trial Optional)

Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21 Clinical Trial Optional)

Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R03 Clinical Trial Optional)

Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional)

Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01 Clinical Trial Optional)

Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R21 Clinical Trial Optional)


CTSA Supplemental Funding Opportunities

Pre-application for the NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (X02 Clinical Trial Not Allowed)

Limited Competition: Clinical and Translational Science Award (CTSA) Program: Exploratory Collaborative Innovation Awards (R21 Clinical Trial Optional)

Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative Innovation Award, (U01 Clinical Trial Optional)


Foundation and Intramural Funding Opportunities
Implementation Science Pilot Grant Opportunity

National Comprehensive Cancer Network Pfizer Biosimilars Research Grant Opportunity

Warren Alpert Distinguished Scholars Fellowship Award

Development Enhancement Awards for Proposals

Faculty Research Enhancement Awards

American Society of Clinical Oncology – Advanced Clinical Research Award

American Society of Clinical Oncology – Career Development Award

American Society of Clinical Oncology – Global Oncology Young Investigator Award

American Society of Clinical Oncology – Young Investigator Award

American Society of Clinical Oncology – Women Who Conquer Cancer Mentorship Awards

Barton Pilot Grants

Hornick Endowment Grants

Sturgis Foundation Grants

College of Medicine Equipment Grants
Know someone who needs to be added to our email list? Send their name to Susan Van Dusen, communications manager.
Copyright © 2021 *|LIST:COMPANY|*, All rights reserved.


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

Email Marketing Powered by Mailchimp